Saturday - May 4, 2024
Icahn School of Medicine: Royalty Pharma Donates $1,000,000 to Support Mount Sinai's COVID-19 Patient Care and Clinical Research
December 23, 2020
NEW YORK, Dec. 23 (TNSRes) -- The Icahn School of Medicine at Mount Sinai issued the following news release on Dec. 21:

Royalty Pharma (Nasdaq: RPRX) today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System. The funds will be used to support:

* Mount Sinai's Center for Post-COVID Care (CPCC) and Post-COVID Registry: Royalty Pharma's charitable contribution will study the long-term consequences of Covid-19 infec . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products